#SmallCellLungCancer
Among Medicare beneficiaries with #SmallCellLungCancer, #LowDoseComputedTomography screening before diagnosis was associated with earlier-stage disease and less distant-stage presentation.

ja.ma/4f0BGu9
November 10, 2026 at 5:47 AM
Kudos to @foxchasecancer.bsky.social for enrolling its first patient in PrE0510, our phase 2 #ClinicalTrial exploring the optimal dose of ivonescimab with carboplatin and etoposide in extensive-stage #SmallCellLungCancer (#SCLC). Learn more: bit.ly/PrE0510
October 27, 2026 at 5:22 PM
BIOTECH · Lung cancer drug combination extends survival in trial

In an interim phase 3 study, patients on Imdelltra plus Imfinzi lived a median 21.1 months, compared with 12.7 months on Imfinzi alone.

Read the full story →

#Biotech #smallcelllungcancer #TheDailyFathom
October 26, 2026 at 12:06 AM
Pope Leo XIV Lung Cancer: Post-Surgery Recovery on Track
..................
https://nile1.com/pope-leo-xiv-lung-cancer-post-surgery-recovery-on-track/
..................
#agostinoGemelliPolyclinic #dr.LuigiCarbone #lobectomy #lungAdenocarcinoma #lungCancer #non-smallCellLungCancer #popeLeoXiv #profe
October 14, 2026 at 5:39 PM
Shout out to @OSUCCC_James & for enrolling its first patient in PrE0510, our phase 2 #ClinicalTrial exploring the optimal dose of ivonescimab with carboplatin and etoposide in extensive-stage #SmallCellLungCancer (#SCLC). Learn more: bit.ly/PrE0510
September 21, 2026 at 3:24 PM
Great work to @luriecancer.bsky.social for enrolling its first patient in PrE0510, our phase 2 #ClinicalTrial exploring the optimal dose of ivonescimab with carboplatin and etoposide in extensive-stage #SmallCellLungCancer (#SCLC). Learn more: bit.ly/PrE0510
September 18, 2026 at 1:18 PM
Nature Medicine has published an author correction for the ABBV-706 phase 1 trial, a SEZ6-targeting antibody-drug conjugate being tested in a…

#ABBV706 #Antibodydrugconjugate #Phase1trial #Precisiononcology #Smallcelllungcancer

#ABBV706 #Antibodydrugconjugate #Phase1trial #Precisiononcology #Sm…
ABBV-706 Phase 1 Trial Correction Published
Nature Medicine has published an author correction for the ABBV-706 phase 1 trial, a SEZ6-targeting antibody-drug conjugate being tested in a… #ABBV706 #Antibodydrugconjugate #Phase1trial #Precisiononcology #Smallcelllungcancer
news.gmj.ge
September 14, 2026 at 7:26 AM
#Amgen's fast-growing cancer #immunotherapy #Imdelltra could move into the first-line setting in #smallcelllungcancer (SCLC), after delivering as a #dualregimen with AstraZeneca's Imfinzi in the DeLLphi-305 study.

pharmaphorum.com/news/amgens-...
Amgen's Imdelltra scores again in small cell lung cancer
Amgen's Imdelltra and AstraZeneca's Imfinzi have improved survival compared to Imfinzi alone as first-line maintenance treatment for ES-SCLC.
pharmaphorum.com
September 9, 2026 at 1:24 PM
Nature Medicine has published an author correction for the ABBV-706 phase 1 trial, a SEZ6-targeting antibody-drug conjugate being tested in a…

#ABBV706 #Antibodydrugconjugate #Phase1trial #Precisiononcology #Smallcelllungcancer

#ABBV706 #Antibodydrugconjugate #Phase1trial #Precisiononcology #Sm…
ABBV-706 Phase 1 Trial Correction Published
Nature Medicine has published an author correction for the ABBV-706 phase 1 trial, a SEZ6-targeting antibody-drug conjugate being tested in a… #ABBV706 #Antibodydrugconjugate #Phase1trial #Precisiononcology #Smallcelllungcancer
news.gmj.ge
September 3, 2026 at 10:41 AM
Dr. Anne Chiang joins #YaleCancerAnswers tonight at 7:30pm and sheds light on #smallcelllungcancer - limited stage vs. extensive stage and shares exciting advances in immunotherapy.
🎧Listen live #WNPR
🔁Download via #ApplePodcasts, #Spotify
💻Listen later #YouTube
August 30, 2026 at 6:49 PM
New hope for #SmallCellLungCancer.
Dana-Farber scientists reveal a new strategy using direct cyclin inhibitors; backed by preclinical evidence & ready for clinical trials. A fresh path in tackling aggressive cancers.
#CancerResearch #LungCancer #TCSC #DanaFarber

www.dana-farber.org/newsroom/new...
New Strategy for Small Cell Lung Cancer Treatment Emerges from Dana-Farber Science | Dana-Farber Cancer Institute
New research from Dana-Farber Cancer Institute shows that a new class of drug results in cancer cell death in cancers, such as small cell lung cancer, with a disabled quality control cell cycle checkp...
www.dana-farber.org
August 21, 2025 at 7:13 AM
🫁  #VHIO hosted the 1st @sosclc-aecc.bsky.social Annual Symposium — bringing together researchers, clinicians, and patient representatives to advance progress in #SmallCellLungCancer research.

➡️ https://linke.to/SOSCLC-AECCVHIO

#AECCVHIO #PulmónVHIO
@cerca.cat @mmalumbres.bsky.social
November 10, 2025 at 6:03 PM
🎯 The 1st #SOSCLCAECC Annual Symposium kicks off today at #VHIO ‼️ 

Two days to strengthen Spain’s national network in #SmallCellLungCancer — fostering dialogue, knowledge exchange, and collaboration among experts and trainees.

🤝 Co-coordinated by Hospital Universitario 12 de Octubre & #VHIO
November 6, 2025 at 7:02 PM
Could tarlatamab improve outcomes for patients with #smallcelllungcancer and #brainmetastases? At #ASCO26, Dr Mountzios reviews data showing improved intracranial PFS, OS, and brain response rates with tarlatamab compared with chemotherapy. ecancer.org/en/video/129...
Tarlatamab improves brain metastases control and survival compared to chemo in SCLC - ecancer
Dr Giannis Mountzios speaks to ecancer about the DeLLphi-304 study. This analysis highlights the intracranial efficacy of tarlatamab, a bispecific T-cell eng
ecancer.org
June 1, 2026 at 9:02 PM
US NIH cancer research funding per death is substantially higher for less-lethal cancers such as #BreastCancer and #ProstateCancer vs highly lethal cancers such as #SmallCellLungCancer and #PancreaticCancer. ja.ma/4vJk9NP
April 24, 2026 at 7:15 PM
Wendy Brooks talks about promising new therapies for small cell lung cancer, including bite therapy and targeted antibody drug conjugates. These treatments bring new hope by focusing directly on cancer cells. Learn more: buff.ly/2zzdc5p

#LivingWithLungCancer #SmallCellLungCancer
August 24, 2025 at 6:15 PM
Lung Cancer Foundation of America continues to create grants for researchers unlocking potential treatments for lung cancer, including small cell lung cancer. Tune into our podcast that touches on the latest technology in SCLC treatment: buff.ly/gctJHGG #CancerResearch #SmallCellLungCancer
April 17, 2025 at 10:00 PM
Dr. Triparna Sen highlights the importance of biomarker-driven strategies in small cell lung cancer research. These advancements are paving the way for more targeted treatments.
#LungCancer #SmallCellLungCancer

Watch the full video here: buff.ly/8Cgv6Qf
April 5, 2025 at 6:15 PM